OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
Abdollah Ardebili, Ahdieh Izanloo, Mostafa Rastegar
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 4, pp. 387-429
Closed Access | Times Cited: 30
Abdollah Ardebili, Ahdieh Izanloo, Mostafa Rastegar
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 4, pp. 387-429
Closed Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1843-1843
Open Access | Times Cited: 24
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1843-1843
Open Access | Times Cited: 24
Nanobiotic Formulations utilizing Quinoline-based-Triazole functionalized Carbon Quantum Dots via Click Chemistry for Combatting Clinical-Resistant Bacterial Pathogens
Nisha Yadav, Deeksha Mudgal, Vivek Mishra
Indian Journal of Microbiology (2024)
Closed Access | Times Cited: 8
Nisha Yadav, Deeksha Mudgal, Vivek Mishra
Indian Journal of Microbiology (2024)
Closed Access | Times Cited: 8
Comparative effectiveness and mortality of colistin monotherapy versus colistin-fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections: A propensity score analysis
Wasan Katip, Ajaree Rayanakorn, Peninnah Oberdorfer, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 5, pp. 727-734
Open Access | Times Cited: 7
Wasan Katip, Ajaree Rayanakorn, Peninnah Oberdorfer, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 5, pp. 727-734
Open Access | Times Cited: 7
Combination antimicrobial therapy: in vitro synergistic effect of anti-staphylococcal drug oxacillin with antimicrobial peptide nisin against Staphylococcus epidermidis clinical isolates and Staphylococcus aureus biofilms
Toktam Sharafi, Ezzat Allah Ghaemi, Maryam Rafiee, et al.
Annals of Clinical Microbiology and Antimicrobials (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Toktam Sharafi, Ezzat Allah Ghaemi, Maryam Rafiee, et al.
Annals of Clinical Microbiology and Antimicrobials (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Prevalence of Multidrug-Resistant Pathogens Causing Neonatal Early and Late Onset Sepsis, a Retrospective Study from the Tertiary Referral Children’s Hospital
Panpan Fang, Kaijie Gao, Junmei Yang, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 4213-4225
Open Access | Times Cited: 15
Panpan Fang, Kaijie Gao, Junmei Yang, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 4213-4225
Open Access | Times Cited: 15
Nanoformulation of Polymyxin E Through Complex Coacervation: A Pharmacokinetic Analysis
Xiaobao Chen, Liu Li, Weidan Wang, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 76-76
Open Access
Xiaobao Chen, Liu Li, Weidan Wang, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 76-76
Open Access
Optimizing meropenem therapy in critical infections: a review of pharmacokinetics/pharmacodynamics research and clinical practice
Jian Liao, Chao Li, Lixia Li
Expert Review of Clinical Pharmacology (2025)
Closed Access
Jian Liao, Chao Li, Lixia Li
Expert Review of Clinical Pharmacology (2025)
Closed Access
In vitro synergistic effects of mefloquine combined with other antimicrobial agents on carbapenem-resistant Enterobacterales
Chunhong Zou, Zixin Wen, Wen Wang, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2025)
Closed Access
Chunhong Zou, Zixin Wen, Wen Wang, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2025)
Closed Access
Polymyxin B in The Treatment of Infections Caused by Multidrug-Resistant Gram-Negative Bacteria in Children: A Retrospective Case Series and A Literature Review
Aihua Yan, Xiangcheng Pan, Siyu Li, et al.
Infection and Drug Resistance (2025) Vol. Volume 18, pp. 965-977
Open Access
Aihua Yan, Xiangcheng Pan, Siyu Li, et al.
Infection and Drug Resistance (2025) Vol. Volume 18, pp. 965-977
Open Access
In Vitro and In Vivo Evaluation of the De Novo Designed Antimicrobial Peptide P6.2 Against a KPC-Producing P. aeruginosa Clinical Isolate
Melina Martínez, Merlina Corleto, Melanie Weschenfeller, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 339-339
Open Access
Melina Martínez, Merlina Corleto, Melanie Weschenfeller, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 339-339
Open Access
Chondroitin Sulfate/Cyanocobalamin–Chitosan Polyelectrolyte Complexes for Improved Oral Delivery of Colistin
Natallia V. Dubashynskaya, Andrey Y. Borovskoy, Anton N. Bokatyi, et al.
Polysaccharides (2025) Vol. 6, Iss. 1, pp. 21-21
Open Access
Natallia V. Dubashynskaya, Andrey Y. Borovskoy, Anton N. Bokatyi, et al.
Polysaccharides (2025) Vol. 6, Iss. 1, pp. 21-21
Open Access
Pharmacodynamic target attainment of the synergism of ceftazidime-avibactam in combination with amikacin against OXA-producing extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa
Yixin Kang, Junchang Cui
European Journal of Clinical Microbiology & Infectious Diseases (2025)
Open Access
Yixin Kang, Junchang Cui
European Journal of Clinical Microbiology & Infectious Diseases (2025)
Open Access
Mortality and clinical outcomes of colistin versus colistin-based combination therapy for infections caused by Multidrug-resistant Acinetobacter baumannii in critically ill patients
Marwan Jabr Alwazzeh, Jumanah Algazaq, Fatimah Hassan Alsalem, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Marwan Jabr Alwazzeh, Jumanah Algazaq, Fatimah Hassan Alsalem, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Intraventricular or intrathecal polymyxin B for treatment of post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria: a 8-year retrospective study
Yangmin Hu, Danyang Li, Gensheng Zhang, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2024) Vol. 43, Iss. 5, pp. 875-884
Open Access | Times Cited: 4
Yangmin Hu, Danyang Li, Gensheng Zhang, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2024) Vol. 43, Iss. 5, pp. 875-884
Open Access | Times Cited: 4
Efficacy and Safety Factors Related to Plasma Concentration-Optimized Polymyxin B Therapy in Treating Carbapenem-Resistant Gram-Negative Bacterial Infections in China
Lixia Li, Xiaohui Huang, Jingxian Liu, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 3057-3071
Open Access | Times Cited: 2
Lixia Li, Xiaohui Huang, Jingxian Liu, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 3057-3071
Open Access | Times Cited: 2
Real-world data on the effects of colistin sulfate and polymyxin B sulfate in the treatment of pneumonia induced by CR-GNB
Di Liu, Jie Fang, Yongjie Ding, et al.
The Journal of Infection in Developing Countries (2024) Vol. 18, Iss. 07, pp. 1050-1057
Open Access | Times Cited: 2
Di Liu, Jie Fang, Yongjie Ding, et al.
The Journal of Infection in Developing Countries (2024) Vol. 18, Iss. 07, pp. 1050-1057
Open Access | Times Cited: 2
Thymol and carvacrol against Klebsiella: anti-bacterial, anti-biofilm, and synergistic activities—a systematic review
Kousha Farhadi, Erta Rajabi, Hesam Aldin Varpaei, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Kousha Farhadi, Erta Rajabi, Hesam Aldin Varpaei, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
A pharmacovigilance study of adverse events associated with polymyxins based on the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database
Tingxi Wu, Yanfeng Shi, Chang Xu, et al.
Expert Opinion on Drug Safety (2024), pp. 1-9
Closed Access | Times Cited: 1
Tingxi Wu, Yanfeng Shi, Chang Xu, et al.
Expert Opinion on Drug Safety (2024), pp. 1-9
Closed Access | Times Cited: 1
Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)
Rajeev Soman, Balaji Veeraraghavan, Ashit Hegde, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 6, pp. 453-468
Closed Access | Times Cited: 1
Rajeev Soman, Balaji Veeraraghavan, Ashit Hegde, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 6, pp. 453-468
Closed Access | Times Cited: 1
Potent synergy and sustained bactericidal activity of polymyxins combined with Gram-positive only class of antibiotics versus four Gram-negative bacteria
Yan Wang, Jianwen Feng, Jiameng Yu, et al.
Annals of Clinical Microbiology and Antimicrobials (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Yan Wang, Jianwen Feng, Jiameng Yu, et al.
Annals of Clinical Microbiology and Antimicrobials (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Bacterial profile, and independent predictors for healthcare-associated pneumonia persistently caused by multidrug-resistant Gram-negative bacteria for patients with the preceding multidrug-resistant Gram-negative pneumonia in Taiwan
Li‐Kuo Kuo, Hou-Tai Chang, Shun-Chung Hsueh, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 5, pp. 801-811
Open Access | Times Cited: 1
Li‐Kuo Kuo, Hou-Tai Chang, Shun-Chung Hsueh, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 5, pp. 801-811
Open Access | Times Cited: 1
Immunomodulator AS101 restores colistin susceptibility of clinical colistin-resistant Escherichia coli and Klebsiella pneumoniae in vitro and in vivo
Haifeng Liu, Ying Zhang, Zeyong Zhong, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 4, pp. 107285-107285
Closed Access | Times Cited: 1
Haifeng Liu, Ying Zhang, Zeyong Zhong, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 4, pp. 107285-107285
Closed Access | Times Cited: 1
Cefiderocol Versus Best Available Therapy in the Treatment of Critically Ill Patients with Severe Infections Due to Resistant Gram-Negative Bacteria: A Systematic Review and Meta-Analysis
Carlos Risco-Risco, César Henríquez-Camacho, Marta Herrera-Rueda, et al.
Antibiotics (2024) Vol. 13, Iss. 11, pp. 1048-1048
Open Access | Times Cited: 1
Carlos Risco-Risco, César Henríquez-Camacho, Marta Herrera-Rueda, et al.
Antibiotics (2024) Vol. 13, Iss. 11, pp. 1048-1048
Open Access | Times Cited: 1
Effectiveness and safety of minocycline combination therapy for the treatment of patients with ventilator-associated pneumonia due to extensively drug- or pandrug-resistant Acinetobacter baumannii
Zoe Athanassa, Sofia Manioudaki, Irina Petsa, et al.
International Journal of Antimicrobial Agents (2024) Vol. 63, Iss. 5, pp. 107129-107129
Closed Access
Zoe Athanassa, Sofia Manioudaki, Irina Petsa, et al.
International Journal of Antimicrobial Agents (2024) Vol. 63, Iss. 5, pp. 107129-107129
Closed Access
Integrons and multidrug resistance across phylogenetic groups of clinical isolates of Escherichia coli
Rimsha Razzaq, Ahmad Sheraz, Muhammad Mohsin, et al.
Pakistan Journal of Medical Sciences (2024) Vol. 40, Iss. 6
Open Access
Rimsha Razzaq, Ahmad Sheraz, Muhammad Mohsin, et al.
Pakistan Journal of Medical Sciences (2024) Vol. 40, Iss. 6
Open Access
